XML 45 R37.htm IDEA: XBRL DOCUMENT v3.26.1

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Summary of Disaggregated Amounts that Comprise Research and Development and General and Administrative Expenses

In addition to the significant expense categories included within consolidated net income (loss) presented on the Company's condensed consolidated statements of operations and comprehensive income (loss), see below for disaggregated amounts that comprise research and development and general and administrative expenses:

		THREE MONTHS ENDED MARCH 31,
		2026				2025
Operating expenses:
Research and development:
Clinical development		$	4,834			$	1,245
Employee-related			4,118				2,152
Facility and equipment costs			347				378
Pre-clinical research			26				117
Other research and development segment expenses			515				124
Total research and development			9,840				4,016
General and administrative:
Employee-related			2,366				1,716
Professional and consulting fees			2,049				1,803
Commercial readiness			1,338				131
Other general and administrative segment expenses (1)			691				464
Total general and administrative			6,444				4,114
Total operating expenses			16,284				8,130
Loss from operations			(16,284	)			(8,130	)
Grant income			22				—
Interest income			1,322				934
Interest expense			(1,564	)			(306	)
Change in fair value of warrant liabilities			7,643				14,881
Net income (loss)		$	(8,861	)		$	7,379

(1) Other general and administrative segment expenses primarily consist of insurance, recruiting, occupancy, and information technology costs.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration